Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.56 USD | -2.61% | -35.92% | -49.98% |
05-08 | Baird Adjusts Price Target on EyePoint Pharmaceuticals to $38 From $46, Keeps Outperform Rating | MT |
05-08 | Earnings Flash (EYPT) EYEPOINT PHARMACEUTICALS Posts Q1 Revenue $11.7M | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Neutral | Neutral |
Resistance | 16.16 | 29.71 | 28.80 |
Spread/Res. | -28.47% | -61.09% | -59.86% |
Spread/Supp. | +3.21% | +92.67% | +95.93% |
Support | 11.20 | 6.000 | 5.900 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- EYPT Stock
- Charts EyePoint Pharmaceuticals, Inc.